The future of treating brain diseases could lie in non-invasive technologies, according to Chongqing Haifu Medical Technology ...
Nexalin Technology, Inc. (Nasdaq: NXL) (the "Company" or "Nexalin"), the leader in non-invasive Deep Intracranial Frequency Stimulation (DIFS) of the brain ...
De Novo FDA submission for moderate-to-severe insomnia HOUSTON, TX, April 22, 2026 (GLOBE NEWSWIRE)-- Nexalin Technology, Inc ...
Validation study targets sub-3-minute results to capture global roadside testing market and significantly reduce analysis time from 10 minutes ...
ANKTIVA approved for patients with certain indications of non-muscle invasive bladder cancer and non-small cell lung cancer -- Commercial availability achieved within two months of announcing MENA ...
Nexalin Technology, Inc. (Nasdaq: NXL) (the "Company" or "Nexalin"), the leader in non-invasive Deep Intracranial Frequency Stimulation (DIFS) of the brain ...
13d
Alpheus Medical Initiates Phase 2b Trial of Investigational Therapy for Newly Diagnosed Glioblastoma
Alpheus Medical, Inc., a private, clinical-stage biotechnology company, today announced the initiation of its Phase 2b ...
An exploration of how targeted nanoparticles and artificial intelligence algorithms combine to locate prostate cancer earlier ...
New technology Intox Collect™ has been completed for collection and analysis of voice and facial recognition data using AI for alcohol and a ...
The global digital health monitoring devices market size is calculated at USD 7.40 billion in 2026 and is expected to reach ...
Biomarkers are redefining how oncology trials are designed, shifting from single-mutation targeting to comprehensive genomic ...
Peyton McDaniel, guard for Sun Belt Conference women's basketball champion James Madison University, says the sam® sustained acoustic medicine device helps her stay healthy, recover faster, and play ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results